461 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
Rank Status Study
21 Recruiting FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Pazopanib;   Drug: 5-FU, Oxaliplatin, Leukovorin (FLO)
22 Unknown  S-1-induced Lacrimal Drainage Obstruction
Condition: Gastric Cancer
Intervention: Drug: S-1
23 Not yet recruiting Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia
Condition: Functional Dyspepsia
Intervention: Drug: Acthrel
24 Recruiting First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Condition: Gastric Cancer
Interventions: Drug: Rilotumumab;   Other: Placebo
25 Unknown  Acupuncture Treatment for Gastroparesis: a Pilot Study
Conditions: Gastroparesis;   Nausea;   Vomiting;   Abdominal Pain
Interventions: Procedure: Acupuncture for gastroparesis;   Procedure: Acupuncture for musculoskeletal pain
26 Recruiting RCT: WLE vs. NBI in Upper Gastrointestinal Endoscopy
Conditions: Gastric Intestinal Metaplasia;   Gastric Cancer
Interventions: Device: narrow band imaging;   Device: white light endoscopy
27 Recruiting Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis
Conditions: Malignant Neoplasm of Stomach;   Secondary Malignant Neoplasm of Peritoneum;   Secondary Malignant Neoplasm of Other and Unspecified Sites
Intervention: Procedure: HIPEC
28 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:
29 Unknown  A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Roux-en Y reconstruction;   Procedure: Billroth-I reconstruction
30 Recruiting Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
Condition: Advanced Gastric Carcinoma
Interventions: Drug: Oxaliplatin capecitabine;   Drug: Oxaliplatin S-1
31 Not yet recruiting The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study
Condition: Gastric Neoplasm
Interventions: Drug: Magnesium Sulfate;   Drug: Normal saline
32 Recruiting Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Pazopanib
33 Recruiting 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
Condition: Gastroenteropancreatic Neuroendocrine Tumors
Intervention: Drug: 68Ga-OPS202
34 Unknown  High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
Conditions: Endoscopy;   Peptic Ulcer;   Bleeding;   Proton Pump Inhibitors
Interventions: Drug: High dose pantoprazole infusion;   Drug: Standard dose pantoprazole infusion
35 Recruiting Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage IIIB Esophageal Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Esophageal Cancer;   Stage IIIC Gastric Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer
Interventions: Drug: cyclodextrin-based polymer-camptothecin CRLX101;   Other: Laboratory biomarker analysis;   Other: Pharmacological studies
36 Unknown  A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial
Condition: Gastric Cancer
Intervention: Procedure: D1 or D2 lymphadenectomy for gastric cancer patients
37 Unknown  Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine;   Drug: Oxaliplatin;   Drug: Epirubicin;   Drug: Capecitabine
38 Not yet recruiting Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer
Conditions: Gastric Tumor;   Early Gastric Cancer
Intervention:
39 Recruiting S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: S-1 plus cisplatin
40 Recruiting A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) and Chemotherapy in Patients With HER2-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: 5-fluorouracil;   Drug: capecitabine;   Drug: cisplatin;   Drug: pertuzumab [Perjeta];   Drug: placebo;   Drug: trastuzumab [Herceptin]

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years